title: Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
authors.affiliation: Organ Transplant Unit, University of Thessaloniki, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Kyriakopoulos
authors.forename: A
authors.initials: A
authors.lastname: Antoniadis
authors.forename: D
authors.initials: D
authors.lastname: Gakis
authors.forename: V
authors.initials: V
authors.lastname: Papanikolaou
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006801:Humans; D016130:Immunophenotyping; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008775:Methylprednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D014019:Tissue Donors
chemical_list: D006684:HLA-DR Antigens; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone